[Arterial hypertension in chronic glomerulonephritis: detectability and treatment efficacy]

Terapevticheskii Arkhiv
|November 10, 2004
PubMed

Insights

Arterial hypertension (AH) is common in chronic glomerulonephritis (CGN), linked to kidney damage and function. Angiotensin-converting enzyme (ACE) inhibitors are the preferred treatment for AH in CGN patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Arterial hypertension (AH) is a significant comorbidity in patients with chronic glomerulonephritis (CGN).
  • Understanding the prevalence and contributing factors of AH in CGN is crucial for effective management.
  • Previous studies have highlighted the complex interplay between renal disease and hypertension.

Purpose of the Study:

  • To determine the prevalence of arterial hypertension (AH) in patients with chronic glomerulonephritis (CGN).
  • To investigate the relationship between AH, renal process activity, and renal function in CGN patients.
  • To analyze the trends and efficacy of antihypertensive therapy in this population.

Main Methods:

  • A cohort of 250 CGN patients treated between 1993 and 2001 was studied.
  • Patients with various morphological variants of CGN were included.
  • Antihypertensive treatment policies and patient outcomes were monitored throughout the study period.

Main Results:

  • AH was highly prevalent, particularly in mesangiocapillary (96.6%) and diffuse fibroplastic nephritis (83.9%).
  • Hypertension occurred in 90.1% of patients with renal functional insufficiency.
  • AH correlated with nephritis activity, tubulointerstitial damage, and metabolic disturbances; age and uric acid were independent predictors.

Conclusions:

  • Arterial hypertension is a frequent complication of CGN, influenced by nephritis type, activity, and renal failure severity.
  • Age, gender, and metabolic factors contribute to AH development in CGN.
  • ACE inhibitors are the drugs of choice for renal AH, with a trend towards increased use of combination therapy.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...